# Study of TVEC in Patients With Cutaneous Squamous Cell Cancer

> **NCT03714828** · PHASE2 · COMPLETED · sponsor: **University of Arizona** · enrollment: 11 (actual)

## Conditions studied

- Squamous Cell Carcinoma
- Skin Cancer
- Keratoacanthoma
- Cutaneous Tumor
- Skin Cancer, Squamous Cell
- Lesion Skin

## Interventions

- **DRUG:** Injection of TVEC into target lesions - week 1-2
- **DRUG:** Injection of TVEC into target lesions 3wks after 1st injection
- **DRUG:** Injection of TVEC into target lesions 2wks after 2nd injection
- **DRUG:** Injection of TVEC into target lesions 2wks after 3rd injection

## Key facts

- **NCT ID:** NCT03714828
- **Lead sponsor:** University of Arizona
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-20
- **Primary completion:** 2023-07-19
- **Final completion:** 2023-07-19
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2024-10-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03714828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03714828, "Study of TVEC in Patients With Cutaneous Squamous Cell Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03714828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*